FDA — authorised 6 April 2006
- Application: NDA021514
- Marketing authorisation holder: NOVEN PHARMS INC
- Local brand name: DAYTRANA
- Indication: FILM, EXTENDED RELEASE — TRANSDERMAL
- Status: approved
🇺🇸 Daytrana in United States
FDA authorised Daytrana on 6 April 2006
Marketing authorisations
FDA
- Status: approved
Daytrana in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Daytrana approved in United States?
Yes. FDA authorised it on 6 April 2006; FDA has authorised it.
Who is the marketing authorisation holder for Daytrana in United States?
NOVEN PHARMS INC holds the US marketing authorisation.